VCEL Q4 2017 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$23M+41.3% YoY

Gross Profit

$15M64.1% margin

Operating Income

$1M5.1% margin

Net Income

$287,0001.2% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

+63.7%

Cash Flow

Operating Cash Flow

$834,000

Free Cash Flow

$116,000

Stock-Based Comp.

$627,000

Balance Sheet

Total Assets

$55M

Total Liabilities

$32M

Stockholders' Equity

$23M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$17M	+41.3%
Gross Profit	$15M	$9M	+67.5%
Operating Income	$1M	-$6M	+120.2%
Net Income	$287,000	-$6M	+104.6%